Arcl Organics Board to Consider Q1 FY27 Results

This is a regulatory disclosure filed with BSE Limited under SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

The Board of Directors meeting is scheduled to be held on Wednesday, August 12, 2026. The agenda includes considering and approving:

• The Unaudited Standalone Financial Results of the Company for the 1st quarter ended June 30, 2026
• The Unaudited Consolidated Financial Results of the Company for the 1st quarter ended June 30, 2026
• Independent Auditor's Limited Review Report on Standalone Financial Results for the 1st quarter ended June 30, 2026
• Independent Auditor's Limited Review Report on Consolidated Financial Results for the 1st quarter ended June 30, 2026

The company has implemented a trading window closure for all Directors, Officers, and Designated Persons of the Company. The closure period extends until 48 hours after the financial results are made public on Wednesday, August 12, 2026.

The disclosure is made pursuant to Regulation 29 read with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The letter is signed by Rajesh Mundhra, Whole Time Director (DIN: 00658649), on behalf of Arcl Organics Limited.